• HSP27 Expression as a Novel Predictive Biomarker for Bevacizumab: is it Cost Effective? 

      Seo, Mikyung Kelly; Straume, Oddbjørn; Akslen, Lars A.; Cairns, John Alexander (Journal article; Peer reviewed, 2020)
      Background: Despite the extensive use of bevacizumab in a range of oncology indications, the US FDA revoked its approval for breast cancers, and multiple negative trials in several solid malignancies have been reported, ...
    • Why do some countries approve a cancer drug and others don’t? 

      Pujolras, Laia Maynou; Cairns, John Alexander (Peer reviewed; Journal article, 2015-06)
      The term drug reimbursement describes the policy system that determines whether or not a drug is entitled to reimbursement within the healthcare system. Countries make different decisions regarding which cancer treatments ...